| Medical management of stable coronary atherosclerosis. | |
| | |
MedLine Citation:
|
PMID: 23423522 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Revascularisation strategies involving coronary artery bypass grafting or percutaneous interventions are the main treatments for stable coronary artery disease, particularly for patients with ongoing symptoms despite medical therapy and/or extensive ischaemia as demonstrated by either non-invasive or invasive means. Irrespective of whether revascularisation is being undertaken, all patients with stable coronary disease require optimal medical therapy in order to reduce the risk of subsequent adverse cardiac events, particularly acute myocardial infarction. The role of medical management has been very actively investigated and reported, particularly because of the global disease burden and the associated high morbidity and mortality. In this review, the current available medical management for the treatment of coronary atherosclerosis is described together with the role and prospects of the newer classes of drugs that are coming into use, and future perspectives in this field. |
| | |
Authors:
|
P Pellicori; P Costanzo; A C Joseph; A Hoye; S L Atkin; J G F Cleland |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current atherosclerosis reports Volume: 15 ISSN: 1534-6242 ISO Abbreviation: Curr Atheroscler Rep Publication Date: 2013 Apr |
Date Detail:
|
Created Date: 2013-02-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897685 Medline TA: Curr Atheroscler Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 313 Citation Subset: IM |
Affiliation:
|
Academic Cardiology Unit, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, HU16 5JQ, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Role of Early LDL Lowering to Prevent the Onset of Atherosclerotic Disease.
Next Document: Metformin therapy in diabetes: the role of cardioprotection.